Role of Matrix Metalloproteinases in Angiogenesis and Cancer
During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metal...
Gespeichert in:
| Veröffentlicht in: | Frontiers in oncology Jg. 9; S. 1370 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
Switzerland
Frontiers Media S.A
06.12.2019
|
| Schlagworte: | |
| ISSN: | 2234-943X, 2234-943X |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis. |
|---|---|
| AbstractList | During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis. During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis.During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the extracellular matrix (ECM), followed by endothelial cell migration, and proliferation and the new generation of matrix components. Matrix metalloproteinases (MMPs) participate in the disruption, tumor neovascularization, and subsequent metastasis while tissue inhibitors of metalloproteinases (TIMPs) downregulate the activity of these MMPs. Then, the angiogenic response can be directly or indirectly mediated by MMPs through the modulation of the balance between pro- and anti-angiogenic factors. This review analyzes recent knowledge on MMPs and their participation in angiogenesis. |
| Author | Arreola, Rodrigo Quintero-Fabián, Saray Ramírez-Camacho, Mario Alberto Alvarez-Sánchez, María Elizbeth Torres-Romero, Julio César Becerril-Villanueva, Enrique Arana-Argáez, Victor Lara-Riegos, Julio |
| AuthorAffiliation | 4 Biochemistry and Molecular Genetics Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán , Merida , Mexico 1 Multidisciplinary Research Laboratory, Military School of Graduate of Health , Mexico City , Mexico 5 Pharmacology Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán , Mérida , Mexico 6 Centro de Información de Medicamentos, Facultad de Química de la Universidad Autónoma de Yucatán , Mérida , Mexico 2 Psychiatric Genetics Department, National Institute of Psychiatry “Ramón de la Fuente”, Clinical Research Branch , Mexico City , Mexico 7 Genomic Sciences Graduate Program, Universidad Autónoma de la Ciudad de Mexico , Mexico City , Mexico 3 Psychoimmunology Laboratory, National Institute of Psychiatry “Ramón de la Fuente” , Mexico City , Mexico |
| AuthorAffiliation_xml | – name: 6 Centro de Información de Medicamentos, Facultad de Química de la Universidad Autónoma de Yucatán , Mérida , Mexico – name: 3 Psychoimmunology Laboratory, National Institute of Psychiatry “Ramón de la Fuente” , Mexico City , Mexico – name: 4 Biochemistry and Molecular Genetics Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán , Merida , Mexico – name: 5 Pharmacology Laboratory, Facultad de Química de la Universidad Autónoma de Yucatán , Mérida , Mexico – name: 2 Psychiatric Genetics Department, National Institute of Psychiatry “Ramón de la Fuente”, Clinical Research Branch , Mexico City , Mexico – name: 7 Genomic Sciences Graduate Program, Universidad Autónoma de la Ciudad de Mexico , Mexico City , Mexico – name: 1 Multidisciplinary Research Laboratory, Military School of Graduate of Health , Mexico City , Mexico |
| Author_xml | – sequence: 1 givenname: Saray surname: Quintero-Fabián fullname: Quintero-Fabián, Saray – sequence: 2 givenname: Rodrigo surname: Arreola fullname: Arreola, Rodrigo – sequence: 3 givenname: Enrique surname: Becerril-Villanueva fullname: Becerril-Villanueva, Enrique – sequence: 4 givenname: Julio César surname: Torres-Romero fullname: Torres-Romero, Julio César – sequence: 5 givenname: Victor surname: Arana-Argáez fullname: Arana-Argáez, Victor – sequence: 6 givenname: Julio surname: Lara-Riegos fullname: Lara-Riegos, Julio – sequence: 7 givenname: Mario Alberto surname: Ramírez-Camacho fullname: Ramírez-Camacho, Mario Alberto – sequence: 8 givenname: María Elizbeth surname: Alvarez-Sánchez fullname: Alvarez-Sánchez, María Elizbeth |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31921634$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kc1rVDEUxYNUbDt27U7e0s1M8z0vIEIZtBZaBFFwF-7LuxlTMsmYZET_e990WmkF7yYhOfd34JxTcpRyQkJeMboQojfnPie34JSZBWViSZ-RE86FnBspvh09uh-Ts1pv6TRaUUbFC3IsmOFMC3lC3n7OEbvsuxtoJfzqbrBBjHlbcsOQoGLtQuou0jrkNSasoXaQxm4FyWF5SZ57iBXP7s8Z-frh_ZfVx_n1p8ur1cX13Cmu2tzzpdCUCkBuFPa9HkYhtRfcMckdR5BejWAMW6qBKorT9JxqCaC0ZE6IGbk6cMcMt3ZbwgbKb5sh2LuHXNYWSgsuogWvvaEgpTGD1GAGp3mvp7gc-tENcmK9O7C2u2GDo8PUCsQn0Kc_KXy36_zTasMUm-KbkTf3gJJ_7LA2uwnVYYyQMO-q5UJoLpdMskn6-rHXX5OH-CeBOghcybUW9NaFBi3kvXWIllG7b9rum7b7pu1d09Pe-T97D-j_bfwBXTmrKw |
| CitedBy_id | crossref_primary_10_1089_dna_2023_0150 crossref_primary_10_3390_ph18020272 crossref_primary_10_1186_s13036_023_00366_4 crossref_primary_10_3390_ijms252111558 crossref_primary_10_37022_wjcmpr_v3i4_185 crossref_primary_10_3390_cancers12061454 crossref_primary_10_1016_j_bbrc_2023_06_077 crossref_primary_10_3390_fermentation9110950 crossref_primary_10_3390_ijms21124490 crossref_primary_10_1016_j_ijbiomac_2024_139318 crossref_primary_10_3390_ijms21145071 crossref_primary_10_1016_j_matbio_2024_12_008 crossref_primary_10_1186_s43094_025_00838_y crossref_primary_10_3390_bios12100884 crossref_primary_10_3390_ijms21103686 crossref_primary_10_3389_fphys_2022_981161 crossref_primary_10_3390_cancers13112775 crossref_primary_10_1016_j_envres_2023_115771 crossref_primary_10_1016_j_jiph_2021_12_004 crossref_primary_10_1038_s41392_023_01460_1 crossref_primary_10_3390_cancers16112029 crossref_primary_10_3390_biomedicines12030619 crossref_primary_10_1016_j_virusres_2023_199091 crossref_primary_10_3390_ijms231911145 crossref_primary_10_3390_ijms241914713 crossref_primary_10_1099_jmm_0_001817 crossref_primary_10_3389_fcell_2023_1207671 crossref_primary_10_1016_j_intimp_2023_110074 crossref_primary_10_1016_j_ejphar_2024_176645 crossref_primary_10_3390_ijms222313120 crossref_primary_10_3390_nu15061439 crossref_primary_10_1002_sstr_202500286 crossref_primary_10_3390_cancers12103053 crossref_primary_10_3390_cells12172144 crossref_primary_10_3390_children8100926 crossref_primary_10_1186_s12967_023_03954_6 crossref_primary_10_1155_2021_9365081 crossref_primary_10_1007_s13402_023_00884_9 crossref_primary_10_1111_iwj_14532 crossref_primary_10_1016_j_adcanc_2025_100141 crossref_primary_10_3389_fphar_2022_1007790 crossref_primary_10_1016_j_taap_2021_115593 crossref_primary_10_1016_j_ejphar_2020_173591 crossref_primary_10_3390_biomedicines9121907 crossref_primary_10_1016_j_taap_2024_117224 crossref_primary_10_1002_cam4_6484 crossref_primary_10_15407_oncology_2025_02_111 crossref_primary_10_1002_fsn3_4744 crossref_primary_10_1111_jre_13094 crossref_primary_10_3390_md23010022 crossref_primary_10_1007_s43630_022_00177_4 crossref_primary_10_3390_cancers17050788 crossref_primary_10_1016_j_ijbiomac_2024_131925 crossref_primary_10_1016_j_biopha_2020_110726 crossref_primary_10_1080_10286020_2025_2497282 crossref_primary_10_3390_pr8121566 crossref_primary_10_1016_j_semcdb_2023_07_002 crossref_primary_10_1016_j_prp_2023_155045 crossref_primary_10_1093_jb_mvad066 crossref_primary_10_1007_s40203_024_00209_0 crossref_primary_10_3389_fcell_2025_1598705 crossref_primary_10_3389_fendo_2022_791860 crossref_primary_10_12677_WJCR_2023_132011 crossref_primary_10_3389_fmolb_2022_896099 crossref_primary_10_3389_ebm_2024_10161 crossref_primary_10_1080_10408398_2024_2384643 crossref_primary_10_2147_CMAR_S385658 crossref_primary_10_1242_jcs_261898 crossref_primary_10_3390_ijms22052514 crossref_primary_10_1016_j_bbcan_2025_189276 crossref_primary_10_1002_cbdv_202201152 crossref_primary_10_3389_fonc_2022_1001126 crossref_primary_10_3390_ijms22116126 crossref_primary_10_4251_wjgo_v13_i8_879 crossref_primary_10_1007_s13205_021_02731_w crossref_primary_10_1016_j_fct_2022_113385 crossref_primary_10_1007_s12032_022_01810_z crossref_primary_10_1007_s12029_021_00600_6 crossref_primary_10_1038_s41551_025_01385_w crossref_primary_10_3390_ijms24021293 crossref_primary_10_3390_ijms26094454 crossref_primary_10_1021_acsami_5c02296 crossref_primary_10_3390_cancers12123709 crossref_primary_10_3390_ph17070921 crossref_primary_10_1016_j_ejcb_2022_151254 crossref_primary_10_1186_s12943_022_01670_1 crossref_primary_10_1155_2021_9599608 crossref_primary_10_1177_00368504221115509 crossref_primary_10_1016_j_actbio_2022_11_065 crossref_primary_10_1016_j_jiec_2023_07_057 crossref_primary_10_1186_s12943_025_02264_3 crossref_primary_10_3390_pharmaceutics15102503 crossref_primary_10_4240_wjgs_v12_i10_407 crossref_primary_10_3390_ijms222011197 crossref_primary_10_1016_j_urolonc_2020_04_034 crossref_primary_10_1016_j_cbi_2024_111361 crossref_primary_10_3390_biom11111739 crossref_primary_10_3389_fcvm_2021_763930 crossref_primary_10_3390_jpm14010103 crossref_primary_10_1111_micc_12817 crossref_primary_10_1007_s12672_025_02246_3 crossref_primary_10_1016_j_lfs_2023_122339 crossref_primary_10_1055_s_0043_1768166 crossref_primary_10_1007_s12033_024_01359_4 crossref_primary_10_1016_j_eml_2021_101498 crossref_primary_10_1080_07391102_2023_2212062 crossref_primary_10_3390_pharmaceutics13040495 crossref_primary_10_1002_ar_25348 crossref_primary_10_3389_fphar_2022_864351 crossref_primary_10_1002_smll_202002436 crossref_primary_10_1016_j_cbi_2021_109433 crossref_primary_10_1016_j_jbc_2022_101833 crossref_primary_10_3390_ijms252313024 crossref_primary_10_1080_10408398_2021_1913568 crossref_primary_10_1080_14756366_2024_2423174 crossref_primary_10_1016_j_ejphar_2022_175089 crossref_primary_10_1016_j_ejphar_2022_175087 crossref_primary_10_1016_j_semcancer_2021_12_011 crossref_primary_10_3390_biom12040491 crossref_primary_10_3390_ijms25147804 crossref_primary_10_1002_1873_3468_14423 crossref_primary_10_1007_s11431_020_1731_8 crossref_primary_10_1002_dvdy_398 crossref_primary_10_3390_cancers13246226 crossref_primary_10_3390_cells12081199 crossref_primary_10_3390_antiox12071386 crossref_primary_10_1016_j_cej_2024_150757 crossref_primary_10_1016_j_micpath_2024_106831 crossref_primary_10_1038_s41467_022_33052_y crossref_primary_10_1371_journal_pone_0300258 crossref_primary_10_1007_s13402_022_00737_x crossref_primary_10_1016_j_ijpharm_2021_120564 crossref_primary_10_1016_j_prp_2024_155130 crossref_primary_10_1007_s11033_022_07348_7 crossref_primary_10_3389_fonc_2020_593245 crossref_primary_10_1016_j_heliyon_2024_e24694 crossref_primary_10_1089_jmf_2021_K_0162 crossref_primary_10_1016_j_cytogfr_2024_10_009 crossref_primary_10_1016_j_seminoncol_2025_152340 crossref_primary_10_1038_s41389_022_00401_x crossref_primary_10_1007_s12672_024_00879_4 crossref_primary_10_1007_s10555_022_10058_y crossref_primary_10_1177_15330338211039126 crossref_primary_10_1126_sciadv_ady1289 crossref_primary_10_3389_fonc_2022_909767 crossref_primary_10_1016_j_talanta_2022_123600 crossref_primary_10_1016_j_toxlet_2023_10_006 crossref_primary_10_3390_nano12010145 crossref_primary_10_1007_s11845_020_02289_1 crossref_primary_10_1002_mabi_202300339 crossref_primary_10_3390_cancers13081946 crossref_primary_10_3390_ijms21186768 crossref_primary_10_3390_ijms252313167 crossref_primary_10_3390_ijms23031181 crossref_primary_10_3390_ijms252313043 crossref_primary_10_3390_cancers14092143 crossref_primary_10_31083_j_fbl2910347 crossref_primary_10_3390_ijms23010146 crossref_primary_10_3390_ijms24021258 crossref_primary_10_3390_cancers15174250 crossref_primary_10_3390_cancers14235903 crossref_primary_10_1097_MD_0000000000025320 crossref_primary_10_1038_s41467_023_42774_6 crossref_primary_10_1038_s41598_025_11804_2 crossref_primary_10_3390_ani11061512 crossref_primary_10_1016_j_biochi_2022_12_015 crossref_primary_10_18282_po3596 crossref_primary_10_3389_fphar_2022_893828 crossref_primary_10_1080_10717544_2022_2055225 crossref_primary_10_1007_s40495_022_00291_y crossref_primary_10_3389_fonc_2021_762817 crossref_primary_10_1002_iid3_70242 crossref_primary_10_1016_j_abb_2025_110436 crossref_primary_10_34133_bmr_0237 crossref_primary_10_7717_peerj_19550 crossref_primary_10_1210_endrev_bnac024 crossref_primary_10_3390_cancers15092515 crossref_primary_10_1007_s00204_020_02702_9 crossref_primary_10_1016_j_prp_2023_154813 crossref_primary_10_3389_fonc_2024_1409627 crossref_primary_10_3390_molecules27207089 crossref_primary_10_3390_cancers14194558 crossref_primary_10_3389_fphar_2024_1355242 crossref_primary_10_3390_life12081140 crossref_primary_10_3390_ijms23147708 crossref_primary_10_3389_fimmu_2021_653358 crossref_primary_10_3390_ijms232415827 crossref_primary_10_3390_pharmaceutics16050654 crossref_primary_10_3390_cancers14071847 crossref_primary_10_1155_2020_8659802 crossref_primary_10_3390_ijms22041802 crossref_primary_10_3390_ijms26167947 crossref_primary_10_1002_ptr_8255 crossref_primary_10_1016_j_biomaterials_2022_121469 crossref_primary_10_1080_07357907_2024_2361295 crossref_primary_10_3390_ijms23073847 crossref_primary_10_3390_ijms222212389 crossref_primary_10_3390_jcm10071436 crossref_primary_10_3390_jcm9124122 crossref_primary_10_1111_jfbc_14468 crossref_primary_10_1016_j_lfs_2023_122021 crossref_primary_10_1016_j_oraloncology_2022_106008 crossref_primary_10_3390_biomedicines12102260 crossref_primary_10_1007_s10456_024_09944_6 crossref_primary_10_1096_fj_202500492RR crossref_primary_10_1002_jbm_a_37799 crossref_primary_10_1016_j_snb_2024_135466 crossref_primary_10_3390_plants13233350 crossref_primary_10_3892_ol_2024_14737 crossref_primary_10_3390_ijms222111694 crossref_primary_10_1016_j_bja_2020_05_003 crossref_primary_10_3390_life15071060 crossref_primary_10_20473_j_djmkg_v54_i3_p150_154 crossref_primary_10_3390_cancers13010010 crossref_primary_10_1134_S1990519X23060135 crossref_primary_10_1002_ijc_33985 crossref_primary_10_3390_cells11030561 crossref_primary_10_1002_ardp_202400299 crossref_primary_10_1002_ptr_7270 crossref_primary_10_1016_j_bcp_2024_116160 crossref_primary_10_1007_s12094_022_02932_6 crossref_primary_10_1371_journal_pone_0283822 crossref_primary_10_1016_j_matbio_2025_08_005 crossref_primary_10_3390_biology14081067 crossref_primary_10_1016_j_ejmech_2022_114817 crossref_primary_10_1080_15257770_2022_2094946 crossref_primary_10_1167_iovs_65_8_2 crossref_primary_10_3389_fphys_2021_735915 crossref_primary_10_3390_ijms222212472 crossref_primary_10_1186_s13104_023_06518_5 crossref_primary_10_1016_j_actbio_2022_11_001 crossref_primary_10_1016_j_mam_2022_101144 crossref_primary_10_3390_cancers15143722 crossref_primary_10_3892_etm_2023_12182 crossref_primary_10_3390_ijms22073608 crossref_primary_10_3389_fonc_2023_1063051 crossref_primary_10_26508_lsa_202302158 crossref_primary_10_3390_cells12071053 crossref_primary_10_1002_iub_2686 crossref_primary_10_1038_s41536_021_00200_9 crossref_primary_10_1016_j_biopha_2023_116016 crossref_primary_10_1089_nat_2021_0111 crossref_primary_10_3390_biom15060781 crossref_primary_10_1089_scd_2024_0088 crossref_primary_10_3390_coatings12020199 crossref_primary_10_1186_s12916_023_03053_9 crossref_primary_10_1002_adfm_202402360 crossref_primary_10_1016_j_jddst_2023_105179 crossref_primary_10_2174_1381612829666221121145614 crossref_primary_10_4070_kcj_2025_0022 crossref_primary_10_3390_biomedicines8090334 crossref_primary_10_3390_app11125532 crossref_primary_10_3389_fimmu_2022_1067661 crossref_primary_10_3390_ijtm4040046 crossref_primary_10_1093_stcltm_szac052 crossref_primary_10_1038_s41433_024_03186_y crossref_primary_10_1016_j_bios_2022_114389 crossref_primary_10_1007_s11356_021_16567_7 crossref_primary_10_1039_D1FO00851J crossref_primary_10_1038_s41598_022_15518_7 crossref_primary_10_3390_biom15081114 crossref_primary_10_3390_proteomes12010001 crossref_primary_10_1007_s12032_025_02754_w crossref_primary_10_1016_j_ejmech_2021_113623 crossref_primary_10_1039_D0FO01531H crossref_primary_10_1016_j_biopha_2024_117585 crossref_primary_10_1080_17460441_2021_1826434 crossref_primary_10_3390_ijms24108894 crossref_primary_10_1016_j_heliyon_2025_e42538 crossref_primary_10_1155_2020_6051210 crossref_primary_10_3390_hemato2020016 crossref_primary_10_1016_j_lfs_2022_120932 crossref_primary_10_1186_s13287_021_02196_x crossref_primary_10_3390_molecules29184360 crossref_primary_10_3892_ijo_2022_5374 crossref_primary_10_1002_aoc_7726 crossref_primary_10_3390_molecules27196441 crossref_primary_10_1007_s11010_020_03932_2 crossref_primary_10_1007_s11033_022_07949_2 crossref_primary_10_1016_j_omto_2022_01_005 crossref_primary_10_1080_1120009X_2021_1908650 crossref_primary_10_1002_cnr2_1946 crossref_primary_10_3390_ijms25168929 crossref_primary_10_1007_s13577_021_00646_5 crossref_primary_10_1111_cas_70120 crossref_primary_10_1002_jcb_70010 crossref_primary_10_1007_s12033_023_00858_0 crossref_primary_10_3390_cancers14153760 crossref_primary_10_3390_cancers14194599 crossref_primary_10_3390_ijms25116012 crossref_primary_10_2147_DDDT_S489113 crossref_primary_10_3390_antiox13020200 crossref_primary_10_1007_s00418_025_02363_8 crossref_primary_10_1016_j_jddst_2024_105384 crossref_primary_10_13005_ojc_410105 crossref_primary_10_3390_ijms222413571 crossref_primary_10_12677_WJCR_2022_122008 crossref_primary_10_3389_fmed_2020_617261 crossref_primary_10_3389_fphys_2023_1137058 crossref_primary_10_3390_ijms21155541 crossref_primary_10_1007_s40944_024_00872_3 crossref_primary_10_3389_fmolb_2024_1425422 crossref_primary_10_1016_j_jmb_2025_169350 crossref_primary_10_1002_mc_23835 crossref_primary_10_2174_0929867329666220823112731 crossref_primary_10_3390_biology12050697 crossref_primary_10_1146_annurev_bioeng_110320_110749 crossref_primary_10_1007_s12094_023_03146_0 crossref_primary_10_3389_fonc_2021_676583 crossref_primary_10_1016_j_bmc_2022_117044 crossref_primary_10_3389_fmicb_2023_1231503 crossref_primary_10_3390_pharmaceutics17060691 crossref_primary_10_1016_j_bioactmat_2025_03_021 crossref_primary_10_1038_s41580_021_00366_6 crossref_primary_10_1002_hsr2_1607 crossref_primary_10_3389_fonc_2022_998274 crossref_primary_10_1093_nar_gkae876 crossref_primary_10_3390_nu13082594 crossref_primary_10_1016_j_intimp_2025_114851 crossref_primary_10_1038_s41598_025_85887_2 crossref_primary_10_3390_cancers15061818 crossref_primary_10_1007_s00403_025_04277_w crossref_primary_10_1007_s10904_023_02541_y crossref_primary_10_1002_adhm_202300153 crossref_primary_10_1016_j_bioorg_2024_107930 crossref_primary_10_1016_j_ejmech_2024_116563 crossref_primary_10_1007_s11684_023_1048_0 crossref_primary_10_1016_j_bcab_2023_102947 crossref_primary_10_3390_cells11233817 crossref_primary_10_1080_87559129_2021_2012792 crossref_primary_10_2147_IJN_S526497 crossref_primary_10_1016_j_prp_2023_154425 crossref_primary_10_1016_j_heliyon_2023_e16292 crossref_primary_10_1002_mabi_202200270 crossref_primary_10_1007_s00210_022_02256_w crossref_primary_10_1002_vms3_1287 crossref_primary_10_1007_s10555_022_10063_1 crossref_primary_10_1177_15347354221128832 crossref_primary_10_3390_metabo13030323 crossref_primary_10_1016_j_jinorgbio_2023_112223 crossref_primary_10_3390_biomedicines10123178 crossref_primary_10_1016_j_talanta_2024_126079 crossref_primary_10_1002_adhm_202400941 crossref_primary_10_3390_cancers16111972 crossref_primary_10_1186_s40164_021_00243_0 crossref_primary_10_1161_CIRCRESAHA_122_321768 crossref_primary_10_1007_s12031_024_02294_4 crossref_primary_10_3389_fcell_2020_602837 crossref_primary_10_3390_molecules27041249 crossref_primary_10_1038_s41577_025_01211_z crossref_primary_10_1016_j_bioorg_2024_107155 crossref_primary_10_1016_j_intimp_2024_112198 crossref_primary_10_3390_ijms24043454 crossref_primary_10_1016_j_biopha_2021_111899 crossref_primary_10_3390_ijms23116245 crossref_primary_10_1111_phpp_70046 crossref_primary_10_3390_molecules26175333 crossref_primary_10_3390_ijms22031381 crossref_primary_10_1080_19420862_2025_2531223 crossref_primary_10_1016_j_heliyon_2024_e30898 crossref_primary_10_1038_s41598_021_85166_w crossref_primary_10_3390_life13020466 crossref_primary_10_3390_endocrines4020027 crossref_primary_10_3389_fcimb_2023_1293351 crossref_primary_10_2147_OTT_S265580 crossref_primary_10_1016_j_actbio_2022_12_015 crossref_primary_10_1016_j_cej_2023_144155 crossref_primary_10_3390_biom11091336 crossref_primary_10_3390_biomedicines11020613 crossref_primary_10_3390_cancers13174367 crossref_primary_10_3390_ijms25010393 crossref_primary_10_3389_fonc_2020_612802 crossref_primary_10_3390_ijms232214336 crossref_primary_10_3389_fmicb_2022_988734 crossref_primary_10_1002_cbin_12097 crossref_primary_10_3390_ijms252413691 crossref_primary_10_3390_ijms24021622 crossref_primary_10_1016_j_jns_2020_117175 crossref_primary_10_3390_biom11060903 crossref_primary_10_3390_ijms21155463 crossref_primary_10_3390_ijms22126514 crossref_primary_10_1016_j_colsurfa_2022_130697 crossref_primary_10_1016_j_yexcr_2024_113930 crossref_primary_10_3390_metabo13080919 crossref_primary_10_1016_j_jddst_2024_106286 crossref_primary_10_1016_j_fbio_2024_105266 crossref_primary_10_3389_fonc_2023_1071751 crossref_primary_10_1038_s12276_024_01310_2 crossref_primary_10_1007_s42452_023_05356_1 crossref_primary_10_3389_fphys_2020_595516 crossref_primary_10_3390_md19070354 crossref_primary_10_3892_ol_2023_13928 crossref_primary_10_1002_jbm_a_37811 crossref_primary_10_3390_ijms22010238 crossref_primary_10_1016_j_indcrop_2024_119589 crossref_primary_10_1016_j_talanta_2023_124523 crossref_primary_10_1016_j_prmcm_2023_100323 crossref_primary_10_3892_mco_2021_2373 crossref_primary_10_3390_antiox14020237 crossref_primary_10_3390_ijms241411446 crossref_primary_10_3390_ijms25052721 crossref_primary_10_3390_cancers14163906 crossref_primary_10_3389_fcell_2021_706286 crossref_primary_10_3390_ijms232416142 crossref_primary_10_1111_febs_16737 crossref_primary_10_1002_prca_202300015 crossref_primary_10_3390_ijms26073083 crossref_primary_10_3389_fcell_2021_642494 crossref_primary_10_1002_mc_23417 crossref_primary_10_3390_cells10081848 crossref_primary_10_3390_ijms26030867 crossref_primary_10_3389_fphar_2021_676399 crossref_primary_10_1016_j_intimp_2022_108585 crossref_primary_10_1002_psc_3561 crossref_primary_10_2147_DNND_S445130 crossref_primary_10_3390_biology14070756 crossref_primary_10_1016_j_jnutbio_2022_109092 crossref_primary_10_1016_j_cell_2023_08_043 crossref_primary_10_1016_j_currproblcancer_2023_101015 crossref_primary_10_3390_cimb46090588 crossref_primary_10_1002_mog2_70007 crossref_primary_10_3390_ijms242417583 crossref_primary_10_1038_s41598_022_21582_w crossref_primary_10_3390_ijms26030871 crossref_primary_10_1016_j_snb_2020_129361 crossref_primary_10_1002_j_2040_4603_2023_tb00284_x crossref_primary_10_1007_s10238_025_01751_7 crossref_primary_10_1016_j_bcp_2022_115124 crossref_primary_10_1080_20002297_2022_2073866 crossref_primary_10_1080_01635581_2021_1931364 crossref_primary_10_1016_j_ygcen_2022_114137 crossref_primary_10_1016_j_semcdb_2021_06_025 crossref_primary_10_1039_D1SC02165F crossref_primary_10_1016_j_jbiotec_2023_12_019 crossref_primary_10_1016_j_cellsig_2022_110389 crossref_primary_10_1016_j_mtcomm_2025_112022 crossref_primary_10_3390_biotech14020028 crossref_primary_10_3390_biomedicines12010026 crossref_primary_10_3390_nu14030531 crossref_primary_10_1016_j_advms_2024_09_007 crossref_primary_10_1016_j_advms_2024_09_008 crossref_primary_10_1016_j_jconrel_2025_114036 crossref_primary_10_3390_genes13040689 crossref_primary_10_3389_fimmu_2023_1196033 crossref_primary_10_1016_j_biomaterials_2022_121578 crossref_primary_10_1080_08923973_2021_1931301 crossref_primary_10_1126_scitranslmed_add2712 crossref_primary_10_1369_00221554211035192 crossref_primary_10_1007_s40199_022_00445_9 crossref_primary_10_1002_mco2_124 crossref_primary_10_1007_s11274_024_04208_3 crossref_primary_10_1080_14786419_2021_1961254 crossref_primary_10_1039_D5DT01074H crossref_primary_10_3390_pharmaceutics14112346 crossref_primary_10_3390_bios15090603 crossref_primary_10_1007_s11033_020_06054_6 crossref_primary_10_1016_j_prp_2022_154256 crossref_primary_10_3390_ijms241310733 crossref_primary_10_7717_peerj_12897 crossref_primary_10_3390_cells12020266 crossref_primary_10_1002_btm2_10704 crossref_primary_10_1002_cbf_3730 crossref_primary_10_1016_j_bbadis_2025_167826 crossref_primary_10_1016_j_phrs_2023_107010 crossref_primary_10_1063_5_0234507 crossref_primary_10_3389_fonc_2023_1251100 crossref_primary_10_3892_mco_2024_2783 crossref_primary_10_1002_mog2_70027 crossref_primary_10_1007_s12032_025_03039_y crossref_primary_10_1016_j_biochi_2024_03_006 crossref_primary_10_1371_journal_pone_0312572 crossref_primary_10_3389_fmolb_2022_1008802 crossref_primary_10_3390_cancers13071598 crossref_primary_10_3389_fphar_2024_1431692 crossref_primary_10_5493_wjem_v15_i2_100166 crossref_primary_10_1007_s12072_023_10615_9 crossref_primary_10_1016_j_chembiol_2023_06_016 crossref_primary_10_3389_fimmu_2023_1169670 crossref_primary_10_1097_MD_0000000000029368 crossref_primary_10_1186_s12894_021_00806_7 crossref_primary_10_1080_15592294_2023_2237761 crossref_primary_10_3390_cells12131692 crossref_primary_10_1007_s11239_020_02329_8 crossref_primary_10_1016_j_pharmthera_2022_108177 crossref_primary_10_1186_s40001_025_02826_7 crossref_primary_10_3390_ijms25137418 crossref_primary_10_3390_biomedicines8050116 crossref_primary_10_1016_j_actbio_2021_01_023 crossref_primary_10_1038_s42003_021_02323_7 crossref_primary_10_1016_j_addr_2021_113974 crossref_primary_10_3390_ijms24129944 crossref_primary_10_3390_cancers15133388 crossref_primary_10_1155_2022_9453270 crossref_primary_10_1016_j_molmed_2022_10_005 crossref_primary_10_1016_j_mtbio_2025_101475 crossref_primary_10_1016_j_prp_2020_153326 crossref_primary_10_3390_ijms23063360 crossref_primary_10_3390_cancers16101872 crossref_primary_10_1186_s12964_024_01932_z crossref_primary_10_1016_j_apmt_2021_101156 crossref_primary_10_1038_s41419_023_05789_x crossref_primary_10_3390_cancers17142393 crossref_primary_10_3389_fcell_2022_945586 crossref_primary_10_3390_ijms222312783 crossref_primary_10_1038_s41598_024_59312_z crossref_primary_10_3390_life12010059 crossref_primary_10_3390_cancers13143453 crossref_primary_10_1038_s41467_021_23789_3 crossref_primary_10_3390_cancers16162924 crossref_primary_10_3390_antiox14060743 crossref_primary_10_3390_pharmaceutics17080980 crossref_primary_10_3390_ijms232416111 crossref_primary_10_1088_1758_5090_ad76d9 crossref_primary_10_3390_cancers17172825 crossref_primary_10_3390_ijms24043842 crossref_primary_10_1007_s43152_020_00015_8 crossref_primary_10_3390_cancers15030958 crossref_primary_10_3390_life14060751 crossref_primary_10_1016_j_phrs_2023_106946 crossref_primary_10_3390_ph14111183 crossref_primary_10_1111_odi_15288 crossref_primary_10_3390_biomedicines12071441 crossref_primary_10_1016_j_prmcm_2023_100302 crossref_primary_10_1042_BST20200208 crossref_primary_10_1080_17425247_2022_2039621 crossref_primary_10_3389_fimmu_2020_609948 crossref_primary_10_1016_j_jcte_2025_100408 crossref_primary_10_3390_cancers13205118 crossref_primary_10_1039_D4NR02795G crossref_primary_10_1177_20417314241299941 crossref_primary_10_17352_2455_8591_000031 crossref_primary_10_3390_ijms23179698 crossref_primary_10_1016_j_ccr_2023_215485 crossref_primary_10_3389_fonc_2023_1259034 crossref_primary_10_1016_j_mce_2023_111998 crossref_primary_10_1016_j_phrs_2021_105648 crossref_primary_10_3390_biotech14030075 crossref_primary_10_1002_ptr_7959 crossref_primary_10_1016_j_tranon_2021_101280 crossref_primary_10_3390_cancers14133263 crossref_primary_10_3390_toxins13080519 crossref_primary_10_3390_ijms25179168 crossref_primary_10_3389_fimmu_2023_1114808 crossref_primary_10_31083_j_jin2202029 crossref_primary_10_1007_s10585_024_10282_6 crossref_primary_10_1016_j_bcp_2022_115262 crossref_primary_10_3390_cancers17172801 crossref_primary_10_3390_ijms25052561 crossref_primary_10_1002_ijc_34289 crossref_primary_10_1016_j_ijpharm_2021_120870 crossref_primary_10_3390_antiox11071377 crossref_primary_10_3389_fnins_2023_1189606 crossref_primary_10_3390_biomedicines12040827 crossref_primary_10_1126_sciadv_adp5958 crossref_primary_10_3390_medicina57070710 crossref_primary_10_3390_cancers15030862 crossref_primary_10_3390_ijms252413558 crossref_primary_10_1128_mbio_00849_25 crossref_primary_10_1016_j_imlet_2021_02_007 crossref_primary_10_3892_etm_2024_12730 crossref_primary_10_1016_j_colsurfb_2024_114014 crossref_primary_10_1002_adhm_202002163 crossref_primary_10_1007_s11010_021_04306_y crossref_primary_10_3390_cancers14030536 crossref_primary_10_3390_molecules27072192 crossref_primary_10_1002_cbdv_202200872 crossref_primary_10_3390_biomedicines11030956 crossref_primary_10_1016_j_ejmech_2022_114439 crossref_primary_10_3390_cancers14246182 crossref_primary_10_3390_cells11152376 crossref_primary_10_3390_ani10030444 crossref_primary_10_33549_physiolres_935228 crossref_primary_10_1016_j_lfs_2022_120495 crossref_primary_10_1016_j_micpath_2024_106649 crossref_primary_10_3390_ijms26125553 crossref_primary_10_1016_j_job_2021_01_006 crossref_primary_10_1371_journal_pone_0282473 crossref_primary_10_1016_j_prp_2023_155024 crossref_primary_10_3390_pharmaceutics14102126 crossref_primary_10_1016_j_ejphar_2023_175586 crossref_primary_10_1002_ijc_35035 crossref_primary_10_3390_nu13092974 crossref_primary_10_3390_ijms232113599 crossref_primary_10_1016_j_ctrv_2024_102749 crossref_primary_10_1007_s00210_025_04128_5 crossref_primary_10_1016_j_ijpharm_2025_126077 crossref_primary_10_3390_ijms26125661 crossref_primary_10_1186_s13046_020_01617_8 crossref_primary_10_1080_08982104_2024_2428168 crossref_primary_10_3390_biomedicines11112953 crossref_primary_10_3892_mmr_2024_13167 crossref_primary_10_1177_02611929231181623 crossref_primary_10_3389_fonc_2022_1108695 crossref_primary_10_1155_2022_2784257 crossref_primary_10_2217_nnm_2022_0243 crossref_primary_10_3390_microorganisms8111824 crossref_primary_10_1016_j_tiv_2021_105138 crossref_primary_10_3390_molecules27134223 crossref_primary_10_1089_rej_2022_0009 crossref_primary_10_3390_ijms21218002 crossref_primary_10_1016_j_ijbiomac_2025_140961 crossref_primary_10_1021_acsomega_5c02394 crossref_primary_10_1016_j_devcel_2021_08_008 crossref_primary_10_3389_fcell_2020_611039 crossref_primary_10_1136_bmjopen_2020_047039 crossref_primary_10_1002_arch_21849 crossref_primary_10_3390_bioengineering10020136 crossref_primary_10_1111_1759_7714_15190 crossref_primary_10_1002_pol_20240302 crossref_primary_10_1002_advs_202200244 crossref_primary_10_1038_s41598_024_73584_5 crossref_primary_10_3390_ijms21186805 crossref_primary_10_1016_j_bios_2021_113653 crossref_primary_10_3390_ijms21103457 crossref_primary_10_3389_fbioe_2023_1296881 |
| Cites_doi | 10.1016/j.cyto.2016.07.013 10.1158/0008-5472.CAN-09-4466 10.3390/biomedicines5020034 10.1136/gutjnl-2011-301179 10.1053/j.gastro.2017.09.039 10.1016/j.bbamcr.2009.04.003 10.4161/onci.24010 10.3390/ijms19123880 10.18632/oncotarget.10194 10.1017/9781107360044.013 10.2147/OTT.S136840 10.1038/onc.2016.240 10.1371/journal.pone.0180097 10.1242/jcs.062711 10.12659/MSM.882614 10.3390/cancers5020617 10.1074/jbc.M308708200 10.1177/1535370216685435 10.1615/CritRevOncog.v18.i1-2.40 10.1161/01.RES.0000070112.80711.3D 10.1155/2014/521754 10.1007/s00432-012-1356-2 10.1038/nrm2183 10.3892/ijo.2016.3653 10.4317/jced.52712 10.1158/0008-5472.CAN-05-1843 10.7150/jca.17648 10.1371/journal.pone.0116006 10.1172/JCI6870 10.1158/1078-0432.CCR-04-1688 10.1016/j.yexcr.2005.11.012 10.1016/j.yexcr.2013.01.010 10.1101/gad.14.2.163 10.1016/j.bbrc.2013.06.046 10.1038/s41598-018-25490-w 10.4049/jimmunol.170.6.3369 10.1158/0008-5472.CAN-13-2994 10.1371/journal.pone.0137923 10.4103/glioma.glioma_10_17 10.1155/2013/928315 10.1186/bcr2195 10.1023/A:1025867130437 10.1074/jbc.M111663200 10.1016/j.molimm.2017.06.034 10.1096/fj.04-2140fje 10.1038/sj.onc.1210463 10.7314/APJCP.2012.13.7.3259 10.3233/CBM-170732 10.18632/oncotarget.15119 10.1016/j.ajpath.2011.05.031 10.1074/jbc.M609570200 10.1158/0008-5472.CAN-12-4495 10.1111/j.1349-7006.2006.00328.x 10.1016/j.cell.2011.09.024 10.1016/j.jss.2008.04.040 10.1038/nrc.2017.51 10.1016/j.matbio.2015.09.003 10.1002/ijc.24702 10.1097/PPO.0000000000000138 10.1016/j.cellsig.2013.06.004 10.1186/s12935-019-0819-9 10.1016/j.bbamcr.2010.01.003 10.1158/0008-5472.CAN-17-0994 10.1186/s12885-015-1466-8 10.18632/oncotarget.11515 10.7150/jca.25666 10.1016/j.biopha.2018.04.022 10.1038/nrc2444 10.1038/onc.2011.602 10.1016/j.cellsig.2013.05.025 10.1002/ijc.32607 10.1186/s13045-017-0408-0 10.1111/j.1582-4934.2009.00764.x 10.1242/jcs.023820 10.1054/bjoc.2000.1487 10.1002/jcp.25808 10.1371/journal.pone.0014250 10.3892/ol.2018.9239 10.1038/onc.2014.2 10.1158/0008-5472.CAN-08-1488 10.1038/nrc1187 10.1016/S0002-9440(10)64887-0 10.1074/jbc.M701737200 10.1016/S1535-6108(03)00133-8 10.1038/nrc865 10.1093/cvr/cvt060 10.1016/S0962-8924(03)00129-6 10.1210/en.2011-1121 10.1111/j.1582-4934.2005.tb00355.x 10.1161/01.RES.0000260801.12916.b5 10.1016/0263-7855(96)00018-5 10.1038/bjc.2014.336 10.4196/kjpp.2014.18.5.391 10.1002/path.4868 10.1074/jbc.272.50.31504 10.18632/oncotarget.10141 10.1016/j.neuroscience.2010.03.064 10.1038/nrc1092 10.1182/blood.V96.8.2673 10.1016/j.phymed.2018.09.172 10.1111/j.1440-1827.2010.02514.x 10.1186/s12885-016-2701-7 10.1172/JCI35213 10.1016/j.bbadis.2015.09.001 10.26355/eurrev_201906_18175 10.1007/s13402-016-0281-9 10.1096/fj.201701103R 10.1016/j.ceb.2004.07.010 10.1038/s41598-017-08581-y 10.3892/or.2017.5426 10.1038/nrc2868 10.7150/ijms.5185 10.1074/mcp.M900381-MCP200 10.1016/j.neo.2016.06.003 10.18632/oncotarget.16819 10.1186/s41021-019-0131-x 10.1038/ncb1800 10.1186/s13059-015-0676-3 10.1016/j.ejcb.2016.06.002 10.3109/14756366.2016.1161620 10.1002/ijc.24479 10.3892/or.2012.1857 10.3389/fphar.2019.00462 10.1073/pnas.0910962106 10.18632/oncotarget.4569 10.1096/fj.01-0790com 10.1186/1476-4598-13-18 10.18632/oncotarget.22526 10.3892/or.2017.5391 10.18632/oncotarget.25863 10.1002/jcb.25219 10.3389/fphar.2011.00111 10.2147/OTT.S155905 10.1016/j.bbcan.2004.09.006 10.1186/s13046-016-0301-7 10.1016/j.pharmthera.2016.09.011 10.1172/JCI34944 10.1038/35036374 10.1038/nrc822 10.1016/j.cytogfr.2005.01.004 10.1074/jbc.M100900200 10.1172/JCI39104 10.1038/cr.1998.17 10.1186/s12943-019-0982-6 10.1038/nature10144 10.1016/j.ccr.2004.10.011 10.3390/cancers6010366 10.3389/fimmu.2014.00144 10.21037/tcr.2018.05.09 10.1002/ijc.25855 10.1074/jbc.M112.417451 10.1182/blood-2008-08-172742 10.1186/s12885-017-3418-y 10.1159/000498857 10.1158/1078-0432.CCR-08-2276 10.3892/or.19.4.1007 10.1074/jbc.R800069200 10.3389/fimmu.2018.00334 10.1016/j.gene.2018.07.018 10.1186/1479-5876-9-216 10.1016/j.mam.2008.05.002 10.1074/jbc.M103608200 10.1002/ijc.27436 10.1083/jcb.106.5.1659 10.1073/pnas.1903330116 10.1136/thoraxjnl-2016-209389 10.1074/jbc.272.46.28823 10.1007/s13277-015-4186-4 10.3892/ol.2015.4035 10.1002/mc.22240 10.1111/odi.12594 10.3892/ijmm.2015.2159 10.1177/1758835919864247 10.1016/j.cardiores.2005.12.002 10.18632/oncotarget.17671 10.1073/pnas.48.6.1014 10.14670/HH-11-708 10.1002/glia.20719 10.1002/jcb.25762 10.3390/cancers6010396 10.1016/j.devcel.2010.05.012 10.1111/jcmm.14342 10.3390/cells7080089 10.1074/jbc.M116.736801 10.3390/jcm6010007 10.1073/pnas.1422445112 10.1186/s12865-018-0241-4 10.1002/cam4.1758 10.1055/s-2008-1068751 10.1016/j.amjsurg.2017.08.003 10.1038/sj.bjc.6605538 10.1074/jbc.M112.373159 10.1038/bjc.2013.745 10.3390/bioengineering5040076 10.3389/fimmu.2017.00205 10.1161/CIRCRESAHA.112.268268 |
| ContentType | Journal Article |
| Copyright | Copyright © 2019 Quintero-Fabián, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argáez, Lara-Riegos, Ramírez-Camacho and Alvarez-Sánchez. Copyright © 2019 Quintero-Fabián, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argáez, Lara-Riegos, Ramírez-Camacho and Alvarez-Sánchez. 2019 Quintero-Fabián, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argáez, Lara-Riegos, Ramírez-Camacho and Alvarez-Sánchez |
| Copyright_xml | – notice: Copyright © 2019 Quintero-Fabián, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argáez, Lara-Riegos, Ramírez-Camacho and Alvarez-Sánchez. – notice: Copyright © 2019 Quintero-Fabián, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argáez, Lara-Riegos, Ramírez-Camacho and Alvarez-Sánchez. 2019 Quintero-Fabián, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argáez, Lara-Riegos, Ramírez-Camacho and Alvarez-Sánchez |
| DBID | AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fonc.2019.01370 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2234-943X |
| ExternalDocumentID | oai_doaj_org_article_af6f90a4499b46a9bc6286338cefdcb4 PMC6915110 31921634 10_3389_fonc_2019_01370 |
| Genre | Journal Article Review |
| GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ADBBV ADRAZ AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EBS EJD EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E OK1 PGMZT RNS RPM ACXDI IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c525t-f2736003ae295e886bd346f32c142c2ea4f5da99175b050eeee82064aa5641c33 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 751 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000504208200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2234-943X |
| IngestDate | Fri Oct 03 12:38:55 EDT 2025 Thu Aug 21 13:50:07 EDT 2025 Thu Sep 04 19:34:16 EDT 2025 Thu Jan 02 23:00:26 EST 2025 Tue Nov 18 22:00:25 EST 2025 Sat Nov 29 01:49:14 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | MT-MMP immune system metalloproteinases MMP angiogenesis and cancer |
| Language | English |
| License | Copyright © 2019 Quintero-Fabián, Arreola, Becerril-Villanueva, Torres-Romero, Arana-Argáez, Lara-Riegos, Ramírez-Camacho and Alvarez-Sánchez. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c525t-f2736003ae295e886bd346f32c142c2ea4f5da99175b050eeee82064aa5641c33 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Reviewed by: Linda C. Meade-Tollin, University of Arizona, United States; Ronca Roberto, University of Brescia, Italy This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology These authors have contributed equally to this work Edited by: Erika Ruiz-Garcia, National Institute of Cancerology (INCan), Mexico |
| OpenAccessLink | https://doaj.org/article/af6f90a4499b46a9bc6286338cefdcb4 |
| PMID | 31921634 |
| PQID | 2336247141 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_af6f90a4499b46a9bc6286338cefdcb4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6915110 proquest_miscellaneous_2336247141 pubmed_primary_31921634 crossref_citationtrail_10_3389_fonc_2019_01370 crossref_primary_10_3389_fonc_2019_01370 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-12-06 |
| PublicationDateYYYYMMDD | 2019-12-06 |
| PublicationDate_xml | – month: 12 year: 2019 text: 2019-12-06 day: 06 |
| PublicationDecade | 2010 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in oncology |
| PublicationTitleAlternate | Front Oncol |
| PublicationYear | 2019 |
| Publisher | Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media S.A |
| References | Shibuya (B50) 2006; 312 Eiró (B166) 2013; 2 Desai (B65) 2013; 25 Ruivo (B170) 2017; 77 Frantz (B204) 2010; 123 Ha (B62) 2016; 86 Zhao (B151) 2004; 279 Jackute (B188) 2018; 19 Skog (B176) 2008; 10 Brew (B15) 2010; 1803 Hanemaaijer (B112) 2002; 272 Kim (B68) 2018; 50 Visse (B30) 2003; 92 Shailender (B201) 2019; 41 Murdoch (B186) 2008; 8 Bielenberg (B8) 2015; 21 Benedito (B37) 2013; 319 Horejs (B6) 2016; 95 Ning (B60) 2018; 103 Liu (B83) 2017; 37 Li (B63) 2003; 170 Yang (B87) 2018; 11 Krstic (B191) 2014; 2014 Host (B153) 2012; 131 Ehrmann (B7) 1968; 41 Long (B91) 2016; 7 Hamano (B116) 2003; 3 Lee (B25) 2013; 25 Maywald (B88) 2015; 112 Kelwick (B16) 2015; 16 B56 Yu (B133) 2000; 14 Huang (B168) 2016; 35 Sang (B34) 1998; 8 Yue (B76) 2016; 16 Su (B200) 2019; 11 Wu (B104) 2018; 7 Shi (B169) 2016; 11 Kujawski (B23) 2008; 118 Shin (B123) 2015; 1852 Said (B121) 2014; 6 Ou (B61) 2015; 6 Seyfried (B3) 2013; 18 Stetler-Stevenson (B35) 1999; 103 Lee (B94) 2008; 19 Paduch (B39) 2016; 39 Zhang (B70) 2019; 23 Winkler (B100) 2004; 6 Chen (B107) 2017; 10 Gupta (B131) 2013; 5 Smith (B36) 1997; 15 Wysoczynski (B172) 2009; 125 B119 Loges (B175) 2009; 15 Park (B53) 2010; 9 Sleeman (B41) 2009; 125 Tallant (B29) 2010; 1803 De Palma (B184) 2017; 17 Saito (B11) 2015; 10 Jabłonska-Trypuć (B22) 2016; 31 Huang (B103) 2013; 10 Larsson (B198) 2019 Ågesen (B102) 2012; 61 Davydova (B43) 2016; 291 Agnihotri (B135) 2001; 276 Majumder (B52) 2018; 5 Yu (B106) 2019; 19 Heusinkveld (B185) 2011; 9 Semenza (B48) 2003; 3 Jin (B136) 2006; 97 Cutler (B71) 2017; 7 Hawinkels (B148) 2010; 70 Aldair (B45) 2010 Zhu (B79) 2008; 10 Basile (B146) 2007; 282 Presta (B178) 2005; 16 Taraboletti (B115) 2002; 160 Chen (B92) 2018; 21 Fabre (B78) 2018; 19 Takafuji (B130) 2007; 26 Chan (B141) 2011; 129 Ito (B111) 2009; 113 Zhang (B81) 2017; 36 Chabottaux (B152) 2009; 13 Bergers (B128) 2000; 2 Hassan (B199) 2012; 13 Luca (B125) 1997; 151 Paye (B154) 2014; 74 Juncker-Jensen (B122) 2013; 73 Thiery (B4) 2002; 2 Li (B93) 2018; 676 Hendrix (B147) 2003; 3 Zou (B90) 2017; 8 B144 Partyka (B127) 2012; 18 Humphrey (B20) 1996; 14 Ren (B82) 2017; 90 Nagase (B14) 2006; 69 Kalluri (B205) 2009; 119 Costanza (B190) 2017; 6 Chen (B18) 2013; 2013 Vannitamby (B181) 2017; 72 Gutwein (B98) 2005; 11 Fang (B114) 2013; 99 Kudo (B137) 2012; 287 Kobori (B84) 2018; 9 Azar (B140) 2011; 152 Gai (B174) 2016; 31 Kridel (B27) 2001; 276 Kahlert (B101) 2014; 110 Hurt (B187) 2017; 214 Matsuo (B161) 2009; 153 Saby (B179) 2019; 10 Rorive (B139) 2008; 56 Burton (B42) 2008; 68 Huang (B55) 2014; 13 Cardoso (B58) 2015; 15 Rundhaug (B32) 2005; 9 Wang (B158) 2017; 8 Adams (B49) 2007; 8 Masson (B132) 2005; 19 Vinnakota (B182) 2017; 232 Chambers (B38) 2002; 2 Jawad (B124) 2010; 5 Mazor (B110) 2013; 288 Sounni (B117) 2011; 2 Ota (B149) 2009; 106 Xia (B96) 2015; 116 Webb (B134) 2017; 17 Eckhard (B26) 2016; 49 Fukushima (B9) 2018; 9 Gross (B17) 1962; 48 Niino (B189) 2010; 60 Lim (B75) 2014; 18 Andisheh-Tadbir (B165) 2016; 8 Sun (B202) 2019; 23 Jayatilaka (B69) 2018; 9 Yu (B5) 2017; 10 Huang (B162) 2018; 154 Wu (B160) 2017; 8 Gomiz-Rüth (B28) 2009; 284 Assent (B180) 2015; 10 Dallas (B192) 2002; 277 Mook (B13) 2004; 1705 Epanchintsev (B64) 2015; 54 Bhoopathi (B129) 2010; 102 Yamamoto (B12) 2013; 139 Tanaka (B95) 2016; 49 Valastyan (B2) 2011; 147 Patterson (B138) 1997; 272 Cheng (B113) 2007; 100 Roomi (B54) 2017; 37 Lee (B24) 2012; 28 Meng (B157) 2019; 18 Xu (B145) 2018; 1 Bates (B67) 2018; 7 Zhou (B85) 2015; 35 Miyake (B10) 2015; 34 Roberts (B44) 2006; 66 Rajabi (B31) 2017; 5 Tjomsland (B105) 2016; 18 Mott (B108) 2004; 16 Prager (B47) 2017 Xiong (B193) 2012; 110 Wang (B19) 2018 Schenk (B109) 2003; 13 Fukui (B57) 2014; 111 Bekes (B183) 2011; 179 Alitalo (B40) 2012; 31 Zucker (B89) 2004; 23 Scott (B77) 2000; 83 Aikins (B164) 2017; 242 Lin (B167) 2017; 241 Chung (B156) 2010; 10 Jadvar (B46) 2017 Ernst (B74) 2008; 118 Sounni (B142) 2002; 16 Lopez (B197) 2019; 116 Lee (B118) 2013; 437 Sun (B173) 2018; 16 Atretkhany (B171) 2016; 168 Yang (B86) 2019; 235 Bruno (B66) 2018; 32 Van den Steen (B195) 2000; 96 Eisenach (B143) 2010; 123 Zergoun (B72) 2016; 37 Espinoza-Sánchez (B59) 2017; 8 Xu (B196) 2018; 8 Elkin (B126) 1999; 59 Gabelloni (B203) 2010; 168 Klinker (B177) 2014; 5 Mahmoodi (B99) 2017; 118 Iizuka (B120) 2014; 6 Liu (B150) 2016; 7 Blank (B159) 2017; 8 Lyons (B194) 1988; 106 Carmeliet (B33) 2011; 473 Ohta (B97) 2017; 23 Amara (B80) 2017; 12 Egeblad (B51) 2010; 18 Murphy (B21) 2008; 29 Di Cara (B1) 2018; 7 Sun (B155) 2007; 282 Hosono (B163) 2017; 8 Chen (B73) 2016; 7 |
| References_xml | – volume: 86 start-page: 64 year: 2016 ident: B62 article-title: Porphyromonas gingivalis increases the invasiveness of oral cancer cells by upregulating IL-8 and MMPs publication-title: Cytokine doi: 10.1016/j.cyto.2016.07.013 – volume: 70 start-page: 4141 year: 2010 ident: B148 article-title: Matrix Metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-09-4466 – volume: 5 start-page: 34 year: 2017 ident: B31 article-title: The role of angiogenesis in cancer treatment publication-title: Biomedicines doi: 10.3390/biomedicines5020034 – volume: 61 start-page: 1560 year: 2012 ident: B102 article-title: ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis publication-title: Gut doi: 10.1136/gutjnl-2011-301179 – volume: 154 start-page: 675 year: 2018 ident: B162 article-title: Interleukin 35 expression correlates with microvessel density in pancreatic ductal adenocarcinoma, recruits monocytes, and promotes growth and angiogenesis of xenograft tumors in mice publication-title: Gastroenterology doi: 10.1053/j.gastro.2017.09.039 – volume: 1803 start-page: 20 year: 2010 ident: B29 article-title: Matrix metalloproteinases: Fold and function of their catalytic domains publication-title: Biochim Biophys Acta Mol Cell Res doi: 10.1016/j.bbamcr.2009.04.003 – volume: 2 start-page: e24010 year: 2013 ident: B166 article-title: Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis publication-title: Oncoimmunology doi: 10.4161/onci.24010 – volume: 19 start-page: 3880 year: 2018 ident: B78 article-title: The interleukin-17 family of cytokines in breast cancer publication-title: Int J Mol Sci doi: 10.3390/ijms19123880 – volume: 7 start-page: 48193 year: 2016 ident: B150 article-title: MT2-MMP induces proteolysis and leads to EMT in carcinomas publication-title: Oncotarget doi: 10.18632/oncotarget.10194 – start-page: 52 volume-title: Molecular Imaging: An Introduction year: 2017 ident: B46 article-title: Chapter 12: Angiogenesis doi: 10.1017/9781107360044.013 – volume: 10 start-page: 4719 year: 2017 ident: B5 article-title: Quercetin inhibits epithelial-mesenchymal transition, decreases invasiveness and metastasis, and reverses IL-6 induced epithelial-mesenchymal transition, expression of MMP by inhibiting STAT3 signaling in pancreatic cancer cells publication-title: Onco Targets Ther doi: 10.2147/OTT.S136840 – volume: 36 start-page: 687 year: 2017 ident: B81 article-title: Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition publication-title: Oncogene doi: 10.1038/onc.2016.240 – volume: 12 start-page: e180097 year: 2017 ident: B80 article-title: Critical role of SIK3 in mediating high salt and IL-17 synergy leading to breast cancer cell proliferation publication-title: PLoS ONE doi: 10.1371/journal.pone.0180097 – volume: 123 start-page: 4182 year: 2010 ident: B143 article-title: MT1-MMP regulates VEGF-A expression through a complex with VEGFR-2 and Src publication-title: J Cell Sci doi: 10.1242/jcs.062711 – volume: 18 start-page: BR130 year: 2012 ident: B127 article-title: VEGF and metalloproteinase 2 (MMP 2) expression in gastric cancer tissue publication-title: Med Sci Monit doi: 10.12659/MSM.882614 – volume: 5 start-page: 617 year: 2013 ident: B131 article-title: Osteopontin and MMP9: associations with VEGF expression/secretion and angiogenesis in PC3 prostate cancer cells publication-title: Cancers doi: 10.3390/cancers5020617 – start-page: 335 volume-title: Biochemical Basis and Therapeutic Implications of Angiogenesis year: 2017 ident: B47 article-title: Angiogenesis in cancer – volume: 279 start-page: 8592 year: 2004 ident: B151 article-title: Differential Inhibition of Membrane Type 3 (MT3)-Matrix Metalloproteinase (MMP) and MT1-MMP by Tissue Inhibitor of Metalloproteinase (TIMP)-2 and TIMP-3 Regulates Pro-MMP-2 activation publication-title: J Biol Chem doi: 10.1074/jbc.M308708200 – volume: 242 start-page: 573 year: 2017 ident: B164 article-title: Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells publication-title: Exp Biol Med doi: 10.1177/1535370216685435 – volume: 18 start-page: 43 year: 2013 ident: B3 article-title: On the origin of cancer metastasis publication-title: Crit Rev Oncog doi: 10.1615/CritRevOncog.v18.i1-2.40 – volume: 92 start-page: 827 year: 2003 ident: B30 article-title: Matrix metalloproteinases and tissue inhibitors of metalloproteinases publication-title: Circ Res doi: 10.1161/01.RES.0000070112.80711.3D – volume: 2014 start-page: 521754 year: 2014 ident: B191 article-title: Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells publication-title: Sci World J doi: 10.1155/2014/521754 – volume: 139 start-page: 533 year: 2013 ident: B12 article-title: Exocyst complex component Sec8: a presumed component in the progression of human oral squamous-cell carcinoma by secretion of matrix metalloproteinases publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-012-1356-2 – volume: 8 start-page: 464 year: 2007 ident: B49 article-title: Molecular regulation of angiogenesis and lymphangiogenesis publication-title: Nat Rev Mol Cell Biol doi: 10.1038/nrm2183 – volume: 49 start-page: 1377 year: 2016 ident: B95 article-title: Enhancement of active MMP release and invasive activity of lymph node metastatic tongue cancer cells by elevated signaling via the TNF-α-TNFR1-NF-B pathway and a possible involvement of angiopoietin-like 4 in lung metastasis publication-title: Int J Oncol doi: 10.3892/ijo.2016.3653 – volume: 8 start-page: e130 year: 2016 ident: B165 article-title: Prognostic value of matrix metalloproteinase-9 expression in oral squamous cell carcinoma and its association with angiogenesis publication-title: J Clin Exp Dent doi: 10.4317/jced.52712 – volume: 66 start-page: 2650 year: 2006 ident: B44 article-title: Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-1843 – volume: 8 start-page: 761 year: 2017 ident: B158 article-title: Role of tumor microenvironment in tumorigenesis publication-title: J Cancer doi: 10.7150/jca.17648 – volume: 10 start-page: e116006 year: 2015 ident: B180 article-title: A Membrane-type-1 matrix metalloproteinase (MT1-MMP) - Discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells publication-title: PLoS ONE doi: 10.1371/journal.pone.0116006 – volume: 103 start-page: 1237 year: 1999 ident: B35 article-title: Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention publication-title: J Clin Invest doi: 10.1172/JCI6870 – volume: 11 start-page: 2492 year: 2005 ident: B98 article-title: Cleavage of L1 in exosomes and apoptotic membrane vesicles released from ovarian carcinoma cells publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-04-1688 – volume: 312 start-page: 549 year: 2006 ident: B50 article-title: Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2005.11.012 – volume: 319 start-page: 1281 year: 2013 ident: B37 article-title: Notch as a hub for signaling in angiogenesis publication-title: Exp Cell Res doi: 10.1016/j.yexcr.2013.01.010 – volume: 14 start-page: 163 year: 2000 ident: B133 article-title: Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angiogenesis publication-title: Genes Dev doi: 10.1101/gad.14.2.163 – volume: 437 start-page: 232 year: 2013 ident: B118 article-title: MT1-MMP regulates MMP-2 expression and angiogenesis-related functions in human umbilical vein endothelial cells publication-title: Biochem Biophys Res Commun doi: 10.1016/j.bbrc.2013.06.046 – volume: 8 start-page: 1 year: 2018 ident: B196 article-title: Matrix metalloproteinases (MMPs) mediate leukocyte recruitment during the inflammatory phase of zebrafish heart regeneration publication-title: Sci Rep doi: 10.1038/s41598-018-25490-w – volume: 170 start-page: 3369 year: 2003 ident: B63 article-title: IL-8 Directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis publication-title: J Immunol doi: 10.4049/jimmunol.170.6.3369 – volume: 74 start-page: 6758 year: 2014 ident: B154 article-title: EGFR Activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-13-2994 – volume: 10 start-page: e0137923 year: 2015 ident: B11 article-title: Semaphorin7A promotion of tumoral growth and metastasis in human oral cancer by regulation of G1 cell cycle and matrix metalloproteases: possible contribution to tumoral angiogenesis publication-title: PLoS ONE doi: 10.1371/journal.pone.0137923 – volume: 1 start-page: 35 year: 2018 ident: B145 article-title: Molecular mechanisms involved in angiogenesis and potential target of antiangiogenesis in human glioblastomas publication-title: Glioma doi: 10.4103/glioma.glioma_10_17 – volume: 2013 start-page: 928315 year: 2013 ident: B18 article-title: Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling publication-title: Mediators Inflamm doi: 10.1155/2013/928315 – volume: 10 start-page: 1 year: 2008 ident: B79 article-title: IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines publication-title: Breast Cancer Res doi: 10.1186/bcr2195 – volume: 23 start-page: 101 year: 2004 ident: B89 article-title: Role of matrix metalloproteinases (MMPs) in colorectal cancer publication-title: Cancer Metastasis Rev doi: 10.1023/A:1025867130437 – volume: 277 start-page: 21352 year: 2002 ident: B192 article-title: Proteolysis of latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by osteoclasts publication-title: J Biol Chem doi: 10.1074/jbc.M111663200 – volume: 90 start-page: 126 year: 2017 ident: B82 article-title: IL-17RB enhances thyroid cancer cell invasion and metastasis via ERK1/2 pathway-mediated MMP-9 expression publication-title: Mol Immunol doi: 10.1016/j.molimm.2017.06.034 – volume: 19 start-page: 234 year: 2005 ident: B132 article-title: Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes publication-title: FASEB J doi: 10.1096/fj.04-2140fje – volume: 26 start-page: 6361 year: 2007 ident: B130 article-title: An osteopontin fragment is essential for tumor cell invasion in hepatocellular carcinoma publication-title: Oncogene doi: 10.1038/sj.onc.1210463 – volume: 13 start-page: 3259 year: 2012 ident: B199 article-title: Curcumin effect on MMPs and TIMPs genes in a breast cancer cell line publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2012.13.7.3259 – volume: 21 start-page: 661 year: 2018 ident: B92 article-title: Effects of exogenous IL-37 on the biological characteristics of human lung adenocarcinoma A549 cells and the chemotaxis of regulatory T cells publication-title: Cancer Biomarkers doi: 10.3233/CBM-170732 – volume: 8 start-page: 20741 year: 2017 ident: B160 article-title: IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway publication-title: Oncotarget doi: 10.18632/oncotarget.15119 – volume: 179 start-page: 1455 year: 2011 ident: B183 article-title: Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation publication-title: Am J Pathol doi: 10.1016/j.ajpath.2011.05.031 – volume: 282 start-page: 6899 year: 2007 ident: B146 article-title: MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D publication-title: J Biol Chem doi: 10.1074/jbc.M609570200 – volume: 73 start-page: 4196 year: 2013 ident: B122 article-title: Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-12-4495 – volume: 97 start-page: 1327 year: 2006 ident: B136 article-title: Matriptase activates stromelysin (MMP-3) and promotes tumor growth and angiogenesis publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2006.00328.x – volume: 147 start-page: 275 year: 2011 ident: B2 article-title: Tumor metastasis: molecular insights and evolving paradigms publication-title: Cell doi: 10.1016/j.cell.2011.09.024 – volume: 153 start-page: 274 year: 2009 ident: B161 article-title: Interleukin-1α secreted by pancreatic cancer cells promotes angiogenesis and its therapeutic implications publication-title: J Surg Res doi: 10.1016/j.jss.2008.04.040 – volume: 17 start-page: 457 year: 2017 ident: B184 article-title: Microenvironmental regulation of tumour angiogenesis publication-title: Nat Rev Cancer doi: 10.1038/nrc.2017.51 – volume: 49 start-page: 37 year: 2016 ident: B26 article-title: Active site specificity profiling of the matrix metalloproteinase family: proteomic identification of 4300 cleavage sites by nine MMPs explored with structural and synthetic peptide cleavage analyses publication-title: Matrix Biol doi: 10.1016/j.matbio.2015.09.003 – volume: 41 start-page: 1329 year: 1968 ident: B7 article-title: Choriocarcinoma: transfilter stimulation of vasoproliferation in the hamster cheek pouch—studied by light and electron microscopy publication-title: J Natl Cancer Inst – volume: 125 start-page: 2747 year: 2009 ident: B41 article-title: Tumor metastasis and the lymphatic vasculature publication-title: Int J Cancer doi: 10.1002/ijc.24702 – volume: 21 start-page: 267 year: 2015 ident: B8 article-title: The Contribution of Angiogenesis to the Process of Metastasis publication-title: Cancer J doi: 10.1097/PPO.0000000000000138 – volume: 25 start-page: 2025 year: 2013 ident: B25 article-title: Interleukin-5 enhances the migration and invasion of bladder cancer cells via ERK1/2-mediated MMP-9/NF-κB/AP-1 pathway: Involvement of the p21WAF1 expression publication-title: Cell Signal doi: 10.1016/j.cellsig.2013.06.004 – volume: 19 start-page: 1 year: 2019 ident: B106 article-title: Hypoxia promotes colorectal cancer cell migration and invasion in a SIRT1-dependent manner publication-title: Cancer Cell Int doi: 10.1186/s12935-019-0819-9 – volume: 1803 start-page: 55 year: 2010 ident: B15 article-title: The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity publication-title: Biochim Biophys Acta doi: 10.1016/j.bbamcr.2010.01.003 – volume: 151 start-page: 1105 year: 1997 ident: B125 article-title: Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis publication-title: Am J Pathol – volume: 77 start-page: 6480 year: 2017 ident: B170 article-title: The biology of cancer exosomes: insights and new perspectives publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-17-0994 – volume: 15 start-page: 1 year: 2015 ident: B58 article-title: Matrix metalloproteases as maestros for the dual role of LPS- and IL-10-stimulated macrophages in cancer cell behaviour publication-title: BMC Cancer doi: 10.1186/s12885-015-1466-8 – volume: 7 start-page: 62425 year: 2016 ident: B73 article-title: Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14 publication-title: Oncotarget doi: 10.18632/oncotarget.11515 – volume: 9 start-page: 3326 year: 2018 ident: B9 article-title: Overexpression of translocation associated membrane protein 2 leading to cancer-associated matrix metalloproteinase activation as a putative metastatic factor for human oral cancer publication-title: J Cancer doi: 10.7150/jca.25666 – volume: 103 start-page: 262 year: 2018 ident: B60 article-title: Co-culture of ovarian cancer stem-like cells with macrophages induced SKOV3 cells stemness via IL-8/STAT3 signaling publication-title: Biomed Pharmacother doi: 10.1016/j.biopha.2018.04.022 – volume: 8 start-page: 618 year: 2008 ident: B186 article-title: The role of myeloid cells in the promotion of tumour angiogenesis publication-title: Nat Rev Cancer doi: 10.1038/nrc2444 – volume: 31 start-page: 4499 year: 2012 ident: B40 article-title: Interaction of tumor cells and lymphatic vessels in cancer progression publication-title: Oncogene doi: 10.1038/onc.2011.602 – volume: 25 start-page: 1780 year: 2013 ident: B65 article-title: Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells publication-title: Cell Signal doi: 10.1016/j.cellsig.2013.05.025 – year: 2019 ident: B198 article-title: The functional interlink between AR and MMP9/VEGF signaling axis is mediated through PIP5K1α/pAKT in prostate cancer publication-title: Int J cancer doi: 10.1002/ijc.32607 – volume: 10 start-page: 36 year: 2017 ident: B107 article-title: Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein publication-title: J Hematol Oncol doi: 10.1186/s13045-017-0408-0 – volume: 13 start-page: 4002 year: 2009 ident: B152 article-title: Membrane-type 4 matrix metalloproteinase (MT4-MMP) induces lung metastasis by alteration of primary breast tumour vascular architecture publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2009.00764.x – volume: 123 start-page: 4195 year: 2010 ident: B204 article-title: The extracellular matrix at a glance publication-title: J Cell Sci doi: 10.1242/jcs.023820 – volume: 83 start-page: 1538 year: 2000 ident: B77 article-title: Exploiting changes in the tumour microenvironment with sequential cytokine and matrix metalloprotease inhibitor treatment in a murine breast cancer model publication-title: Br J Cancer doi: 10.1054/bjoc.2000.1487 – volume: 232 start-page: 3468 year: 2017 ident: B182 article-title: M2-like macrophages induce colon cancer cell invasion via matrix metalloproteinases publication-title: J Cell Physiol doi: 10.1002/jcp.25808 – volume: 5 start-page: e14250 year: 2010 ident: B124 article-title: Matrix metalloproteinase 1: role in sarcoma biology publication-title: PLoS ONE doi: 10.1371/journal.pone.0014250 – volume: 16 start-page: 4953 year: 2018 ident: B173 article-title: Expression of Livin and PlGF in human osteosarcoma is associated with tumor progression and clinical outcome publication-title: Oncol Lett doi: 10.3892/ol.2018.9239 – volume: 34 start-page: 890 year: 2015 ident: B10 article-title: Angiogenin promotes tumoral growth and angiogenesis by regulating matrix metallopeptidase-2 expression via the ERK1/2 pathway publication-title: Oncogene doi: 10.1038/onc.2014.2 – volume: 68 start-page: 7828 year: 2008 ident: B42 article-title: Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-1488 – volume: 3 start-page: 721 year: 2003 ident: B48 article-title: Targeting HIF-1 for cancer therapy publication-title: Nat Rev Cancer doi: 10.1038/nrc1187 – volume: 160 start-page: 673 year: 2002 ident: B115 article-title: Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells publication-title: Am J Pathol doi: 10.1016/S0002-9440(10)64887-0 – volume: 282 start-page: 21998 year: 2007 ident: B155 article-title: MMP25 (MT6-MMP) is highly expressed in human colon cancer, promotes tumor growth, and exhibits unique biochemical properties publication-title: J Biol Chem doi: 10.1074/jbc.M701737200 – start-page: 1 volume-title: Angiogenesis year: 2010 ident: B45 article-title: Chapter 1: Overview of angiogenesis – volume: 3 start-page: 589 year: 2003 ident: B116 article-title: Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin publication-title: Cancer Cell doi: 10.1016/S1535-6108(03)00133-8 – volume: 2 start-page: 563 year: 2002 ident: B38 article-title: Dissemination and growth of cancer cells in metastatic sites publication-title: Nat Rev Cancer doi: 10.1038/nrc865 – volume: 99 start-page: 146 year: 2013 ident: B114 article-title: An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo publication-title: Cardiovasc Res doi: 10.1093/cvr/cvt060 – volume: 13 start-page: 366 year: 2003 ident: B109 article-title: Tales from the crypt[ic] sites of the extracellular matrix publication-title: Trends Cell Biol doi: 10.1016/S0962-8924(03)00129-6 – volume: 152 start-page: 3332 year: 2011 ident: B140 article-title: IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells publication-title: Endocrinology doi: 10.1210/en.2011-1121 – volume: 9 start-page: 267 year: 2005 ident: B32 article-title: Matrix metalloproteinases and angiogenesis Angiogenesis Review Series publication-title: J Cell Mol Med doi: 10.1111/j.1582-4934.2005.tb00355.x – volume: 100 start-page: 904 year: 2007 ident: B113 article-title: Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice publication-title: Circ Res doi: 10.1161/01.RES.0000260801.12916.b5 – volume: 14 start-page: 33 year: 1996 ident: B20 article-title: VMD: Visual molecular dynamics publication-title: J Mol Graph doi: 10.1016/0263-7855(96)00018-5 – volume: 111 start-page: 763 year: 2014 ident: B57 article-title: IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signaling publication-title: Br J Cancer doi: 10.1038/bjc.2014.336 – volume: 18 start-page: 391 year: 2014 ident: B75 article-title: Inhibition of the interleukin-11-STAT3 axis attenuates hypoxia-induced migration and invasion in MDA-MB-231 breast cancer cells publication-title: Korean J Physiol Pharmacol doi: 10.4196/kjpp.2014.18.5.391 – volume: 241 start-page: 638 year: 2017 ident: B167 article-title: Loss of dual-specificity phosphatase-2 promotes angiogenesis and metastasis via up-regulation of interleukin-8 in colon cancer publication-title: J Pathol doi: 10.1002/path.4868 – ident: B56 – volume: 272 start-page: 31504 year: 2002 ident: B112 article-title: Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells publication-title: J Biol Chem doi: 10.1074/jbc.272.50.31504 – volume: 7 start-page: 45678 year: 2016 ident: B91 article-title: IL-35 expression in hepatocellular carcinoma cells is associated with tumor progression publication-title: Oncotarget doi: 10.18632/oncotarget.10141 – volume: 168 start-page: 514 year: 2010 ident: B203 article-title: Inhibition of metalloproteinases derived from tumours: new insights in the treatment of human glioblastoma publication-title: Neuroscience doi: 10.1016/j.neuroscience.2010.03.064 – volume: 3 start-page: 411 year: 2003 ident: B147 article-title: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma publication-title: Nat Rev Cancer doi: 10.1038/nrc1092 – volume: 96 start-page: 2673 year: 2000 ident: B195 article-title: Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact publication-title: Blood doi: 10.1182/blood.V96.8.2673 – volume: 50 start-page: 35 year: 2018 ident: B68 article-title: Orientin inhibits invasion by suppressing MMP-9 and IL-8 expression via the PKCα/ ERK/AP-1/STAT3-mediated signaling pathways in TPA-treated MCF-7 breast cancer cells publication-title: Phytomedicine doi: 10.1016/j.phymed.2018.09.172 – volume: 60 start-page: 278 year: 2010 ident: B189 article-title: Ratio of M2 macrophage expression is closely associated with poor prognosis for Angioimmunoblastic T-cell lymphoma (AITL) publication-title: Pathol Int doi: 10.1111/j.1440-1827.2010.02514.x – volume: 16 start-page: 1 year: 2016 ident: B76 article-title: Interleukin 12 shows a better curative effect on lung cancer than paclitaxel and cisplatin doublet chemotherapy publication-title: BMC Cancer doi: 10.1186/s12885-016-2701-7 – volume: 118 start-page: 3367 year: 2008 ident: B23 article-title: angiogenesis in mice Find the latest version : Stat3 mediates myeloid cell – dependent tumor angiogenesis in mice doi: 10.1172/JCI35213 – volume: 1852 start-page: 2593 year: 2015 ident: B123 article-title: Regulation of MMP-1 expression in response to hypoxia is dependent on the intracellular redox status of metastatic bladder cancer cells publication-title: Biochim Biophys Acta - Mol Basis Dis doi: 10.1016/j.bbadis.2015.09.001 – volume: 23 start-page: 5113 year: 2019 ident: B202 article-title: MiR-93-5p promotes cervical cancer progression by targeting THBS2/MMPS signal pathway publication-title: Eur Rev Med Pharmacol Sci doi: 10.26355/eurrev_201906_18175 – volume: 39 start-page: 397 year: 2016 ident: B39 article-title: The role of lymphangiogenesis and angiogenesis in tumor metastasis publication-title: Cell Oncol doi: 10.1007/s13402-016-0281-9 – volume: 32 start-page: 5365 year: 2018 ident: B66 article-title: Angiogenin and the MMP9-TIMP2 axis are up-regulated in proangiogenic, decidual NK-like cells from patients with colorectal cancer publication-title: FASEB J doi: 10.1096/fj.201701103R – volume: 16 start-page: 558 year: 2004 ident: B108 article-title: Regulation of matrix biology by matrix metalloproteinases publication-title: Curr Opin Cell Biol doi: 10.1016/j.ceb.2004.07.010 – volume: 7 start-page: 1 year: 2017 ident: B71 article-title: Novel STAT binding elements mediate IL-6 regulation of MMP-1 and MMP-3 publication-title: Sci Rep doi: 10.1038/s41598-017-08581-y – volume: 37 start-page: 1779 year: 2017 ident: B83 article-title: Interleukin-17A promotes esophageal adenocarcinoma cell invasiveness through ROS-dependent, NF-κB-mediated MMP-2/9 activation publication-title: Oncol Rep doi: 10.3892/or.2017.5426 – volume: 10 start-page: 505 year: 2010 ident: B156 article-title: Targeting the tumour vasculature: Insights from physiological angiogenesis publication-title: Nat Rev Cancer doi: 10.1038/nrc2868 – volume: 10 start-page: 276 year: 2013 ident: B103 article-title: Increased co-expression of macrophage migration in-hibitory factor and matrix metalloproteinase 9 is as-sociated with tumor recurrence of meningioma publication-title: Int J Med Sci doi: 10.7150/ijms.5185 – volume: 9 start-page: 1085 year: 2010 ident: B53 article-title: Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes publication-title: Mol Cell Proteomics doi: 10.1074/mcp.M900381-MCP200 – ident: B144 – volume: 18 start-page: 447 year: 2016 ident: B105 article-title: Profile of MMP and TIMP expression in human pancreatic stellate cells: regulation by IL-1α and TGFβ and implications for migration of pancreatic cancer cells publication-title: Neoplasia doi: 10.1016/j.neo.2016.06.003 – volume: 8 start-page: 33501 year: 2017 ident: B90 article-title: IL-35 induces N2 phenotype of neutrophils to promote tumor growth publication-title: Oncotarget doi: 10.18632/oncotarget.16819 – volume: 41 start-page: 16 year: 2019 ident: B201 article-title: Effect of MMP-2 gene silencing on radiation-induced DNA damage in human normal dermal fibroblasts and breast cancer cells publication-title: Genes Environ Off J Japanese Environ Mutagen Soc doi: 10.1186/s41021-019-0131-x – volume: 10 start-page: 1470 year: 2008 ident: B176 article-title: Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers publication-title: Nat Cell Biol doi: 10.1038/ncb1800 – volume: 16 start-page: 113 year: 2015 ident: B16 article-title: The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family publication-title: Genome Biol doi: 10.1186/s13059-015-0676-3 – volume: 95 start-page: 427 year: 2016 ident: B6 article-title: Basement membrane fragments in the context of the epithelial-to-mesenchymal transition publication-title: Eur J Cell Biol doi: 10.1016/j.ejcb.2016.06.002 – volume: 31 start-page: 177 year: 2016 ident: B22 article-title: Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs publication-title: J Enzyme Inhib Med Chem doi: 10.3109/14756366.2016.1161620 – volume: 125 start-page: 1595 year: 2009 ident: B172 article-title: Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumors publication-title: Int J Cancer doi: 10.1002/ijc.24479 – volume: 28 start-page: 1084 year: 2012 ident: B24 article-title: IL-5-induced migration via ERK1/2-mediated MMP-9 expression by inducing activation of NF-κB in HT1376 cells publication-title: Oncol Rep doi: 10.3892/or.2012.1857 – volume: 10 start-page: 462 year: 2019 ident: B179 article-title: DDR1 and MT1-MMP expression levels are determinant for triggering BIK-mediated apoptosis by 3D Type I collagen matrix in invasive basal-like breast carcinoma cells publication-title: Front Pharmacol doi: 10.3389/fphar.2019.00462 – volume: 106 start-page: 20318 year: 2009 ident: B149 article-title: Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1 publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0910962106 – volume: 6 start-page: 26065 year: 2015 ident: B61 article-title: Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals publication-title: Oncotarget doi: 10.18632/oncotarget.4569 – volume: 16 start-page: 555 year: 2002 ident: B142 article-title: MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression publication-title: FASEB J doi: 10.1096/fj.01-0790com – volume: 13 start-page: 1 year: 2014 ident: B55 article-title: IL-1β-induced activation of p38 promotes metastasis in gastric adenocarcinoma via upregulation of AP-1/c-fos, MMP2 and MMP9 publication-title: Mol Cancer doi: 10.1186/1476-4598-13-18 – volume: 8 start-page: 106071 year: 2017 ident: B163 article-title: CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells publication-title: Oncotarget doi: 10.18632/oncotarget.22526 – volume: 37 start-page: 1907 year: 2017 ident: B54 article-title: Modulation of MMP-2 and MMP-9 secretion by cytokines, inducers and inhibitors in human glioblastoma T-98G cells publication-title: Oncol Rep doi: 10.3892/or.2017.5391 – volume: 9 start-page: 32556 year: 2018 ident: B69 article-title: Tumor cell density regulates matrix metalloproteinases for enhanced migration publication-title: Oncotarget doi: 10.18632/oncotarget.25863 – volume: 116 start-page: 2766 year: 2015 ident: B96 article-title: C/EBPβ mediates TNF-α-induced cancer cell migration by inducing MMP expression dependent on p38 MAPK publication-title: J Cell Biochem doi: 10.1002/jcb.25219 – volume: 2 start-page: 111 year: 2011 ident: B117 article-title: MT-MMPS as regulators of vessel stability associated with angiogenesis publication-title: Front Pharmacol doi: 10.3389/fphar.2011.00111 – volume: 11 start-page: 843 year: 2018 ident: B87 article-title: Interleukin-33 enhanced the migration and invasiveness of human lung cancer cells publication-title: Onco Targets Ther doi: 10.2147/OTT.S155905 – volume: 1705 start-page: 69 year: 2004 ident: B13 article-title: The role of gelatinases in colorectal cancer progression and metastasis publication-title: Biochim Biophys Acta Rev Cancer doi: 10.1016/j.bbcan.2004.09.006 – volume: 35 start-page: 1 year: 2016 ident: B168 article-title: Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis publication-title: J Exp Clin Cancer Res doi: 10.1186/s13046-016-0301-7 – volume: 168 start-page: 98 year: 2016 ident: B171 article-title: Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment publication-title: Pharmacol Ther doi: 10.1016/j.pharmthera.2016.09.011 – volume: 118 start-page: 1727 year: 2008 ident: B74 article-title: STAT3 and STAT1 mediate IL-11–dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice publication-title: J Clin Invest doi: 10.1172/JCI34944 – volume: 2 start-page: 737 year: 2000 ident: B128 article-title: Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis publication-title: Nat Cell Biol doi: 10.1038/35036374 – volume: 2 start-page: 442 year: 2002 ident: B4 article-title: Epithelial–mesenchymal transitions in tumour progression publication-title: Nat Rev Cancer doi: 10.1038/nrc822 – volume: 16 start-page: 159 year: 2005 ident: B178 article-title: Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis publication-title: Cytokine Growth Factor Rev doi: 10.1016/j.cytogfr.2005.01.004 – volume: 276 start-page: 20572 year: 2001 ident: B27 article-title: Substrate hydrolysis by matrix metalloproteinase-9 publication-title: J Biol Chem doi: 10.1074/jbc.M100900200 – volume: 59 start-page: 4111 year: 1999 ident: B126 article-title: Inhibition of bladder carcinoma angiogenesis, stromal support, and tumor growth by halofuginone publication-title: Cancer Res – volume: 119 start-page: 1420 year: 2009 ident: B205 article-title: The basics of epithelial-mesenchymal transition publication-title: J Clin Invest doi: 10.1172/JCI39104 – volume: 8 start-page: 171 year: 1998 ident: B34 article-title: MINIREVIEW Complex role of matrix metalloproteinases in angiogen- esis publication-title: Cell Res doi: 10.1038/cr.1998.17 – volume: 18 start-page: 1 year: 2019 ident: B157 article-title: Exosome-orchestrated hypoxic tumor microenvironment publication-title: Mol Cancer doi: 10.1186/s12943-019-0982-6 – volume: 473 start-page: 298 year: 2011 ident: B33 article-title: Molecular mechanisms and clinical applications of angiogenesis publication-title: Nature doi: 10.1038/nature10144 – volume: 6 start-page: 553 year: 2004 ident: B100 article-title: Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.10.011 – volume: 6 start-page: 366 year: 2014 ident: B121 article-title: The role of matrix metalloproteinases in colorectal cancer publication-title: Cancers doi: 10.3390/cancers6010366 – volume: 5 start-page: 144 year: 2014 ident: B177 article-title: Human B cell-derived lymphoblastoid cell lines constitutively produce fas ligand and secrete MHCII(+)FasL(+) killer exosomes publication-title: Front Immunol doi: 10.3389/fimmu.2014.00144 – volume: 7 start-page: 533 year: 2018 ident: B67 article-title: Matrix metalloproteinase (MMP) and immunosuppressive biomarker profiles of seven head and neck squamous cell carcinoma (HNSCC) cell lines publication-title: Transl Cancer Res doi: 10.21037/tcr.2018.05.09 – volume: 129 start-page: 1826 year: 2011 ident: B141 article-title: Catalytic activity of matrix metalloproteinase-19 is essential for tumor suppressor and anti-angiogenic activities in nasopharyngeal carcinoma publication-title: Int J Cancer doi: 10.1002/ijc.25855 – volume: 288 start-page: 598 year: 2013 ident: B110 article-title: Matrix metalloproteinase-1-mediated up-regulation of vascular endothelial growth factor-2 in endothelial cells publication-title: J Biol Chem doi: 10.1074/jbc.M112.417451 – volume: 113 start-page: 2363 year: 2009 ident: B111 article-title: Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells publication-title: Blood doi: 10.1182/blood-2008-08-172742 – volume: 17 start-page: 434 year: 2017 ident: B134 article-title: Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma publication-title: BMC Cancer doi: 10.1186/s12885-017-3418-y – volume: 235 start-page: 225 year: 2019 ident: B86 article-title: IL-33/ST2 axis regulates vasculogenic mimicry via ERK1/2-MMP-2/9 pathway in melanoma publication-title: Dermatology doi: 10.1159/000498857 – volume: 15 start-page: 3648 year: 2009 ident: B175 article-title: “Antimyeloangiogenic” therapy for cancer by inhibiting PlGF publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-08-2276 – volume: 19 start-page: 1007 year: 2008 ident: B94 article-title: Activation of matrix metalloproteinase-9 by TNF-α in human urinary bladder cancer HT1376 cells.pdf publication-title: Oncol Rep doi: 10.3892/or.19.4.1007 – volume: 284 start-page: 15353 year: 2009 ident: B28 article-title: Catalytic domain architecture of metzincin metalloproteases publication-title: J Biol Chem doi: 10.1074/jbc.R800069200 – volume: 9 start-page: 334 year: 2018 ident: B84 article-title: Interleukin-18 amplifies macrophage polarization and morphological alteration, leading to excessive angiogenesis publication-title: Front Immunol doi: 10.3389/fimmu.2018.00334 – volume: 676 start-page: 101 year: 2018 ident: B93 article-title: Horizontal transfer of exosomal CXCR4 promotes murine hepatocarcinoma cell migration, invasion and lymphangiogenesis publication-title: Gene doi: 10.1016/j.gene.2018.07.018 – volume: 9 start-page: 216 year: 2011 ident: B185 article-title: Identification and manipulation of tumor associated macrophages in human cancers publication-title: J Transl Med doi: 10.1186/1479-5876-9-216 – volume: 29 start-page: 290 year: 2008 ident: B21 article-title: Progress in matrix metalloproteinase research publication-title: Mol Aspects Med doi: 10.1016/j.mam.2008.05.002 – volume: 276 start-page: 28261 year: 2001 ident: B135 article-title: Osteopontin, a novel substrate for matrix metalloproteinase-3 (Stromelysin-1) and matrix metalloproteinase-7 (Matrilysin) publication-title: J Biol Chem doi: 10.1074/jbc.M103608200 – ident: B119 – volume: 131 start-page: 1537 year: 2012 ident: B153 article-title: The proteolytic activity of MT4-MMP is required for its pro-angiogenic and pro-metastatic promoting effects publication-title: Int J Cancer doi: 10.1002/ijc.27436 – volume: 106 start-page: 1659 year: 1988 ident: B194 article-title: Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium publication-title: J Cell Biol doi: 10.1083/jcb.106.5.1659 – volume: 116 start-page: 16314 year: 2019 ident: B197 article-title: Functional selection of protease inhibitory antibodies publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1903330116 – volume: 72 start-page: 1140 year: 2017 ident: B181 article-title: Tumour-associated neutrophils and loss of epithelial PTEN can promote corticosteroid-insensitive MMP-9 expression in the chronically inflamed lung microenvironment publication-title: Thorax doi: 10.1136/thoraxjnl-2016-209389 – volume: 272 start-page: 28823 year: 1997 ident: B138 article-title: Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/Type IV collagenase (MMP-9) publication-title: J Biol Chem doi: 10.1074/jbc.272.46.28823 – volume: 37 start-page: 3505 year: 2016 ident: B72 article-title: IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients publication-title: Tumor Biol doi: 10.1007/s13277-015-4186-4 – volume: 11 start-page: 1043 year: 2016 ident: B169 article-title: Interleukin-8: a potent promoter of angiogenesis in gastric cancer publication-title: Oncol Lett doi: 10.3892/ol.2015.4035 – volume: 54 start-page: 1686 year: 2015 ident: B64 article-title: IL-6, IL-8, MMP-2, MMP-9 are overexpressed in Fanconi anemia cells through a NF-κB/TNF-α dependent mechanism publication-title: Mol Carcinog doi: 10.1002/mc.22240 – volume: 23 start-page: 199 year: 2017 ident: B97 article-title: TNF-α-induced IL-6 and MMP-9 expression in immortalized ameloblastoma cell line established by hTERT publication-title: Oral Dis doi: 10.1111/odi.12594 – volume: 35 start-page: 1729 year: 2015 ident: B85 article-title: Interleukin-32 stimulates osteosarcoma cell invasionand motility via AKT pathway-mediated MMP-13 expression publication-title: Int J Mol Med doi: 10.3892/ijmm.2015.2159 – start-page: 241 volume-title: Advances in Pharmacology year: 2018 ident: B19 article-title: Chapter 8: Matrix metalloproteinases, vascular remodeling, and vascular disease – volume: 11 start-page: 175883591986424 year: 2019 ident: B200 article-title: TIMP-3 as a therapeutic target for cancer publication-title: Ther Adv Med Oncol doi: 10.1177/1758835919864247 – volume: 69 start-page: 562 year: 2006 ident: B14 article-title: Structure and function of matrix metalloproteinases and TIMPs publication-title: Cardiovasc Res doi: 10.1016/j.cardiores.2005.12.002 – volume: 8 start-page: 47518 year: 2017 ident: B159 article-title: Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer publication-title: Oncotarget doi: 10.18632/oncotarget.17671 – volume: 48 start-page: 1014 year: 1962 ident: B17 article-title: Collagenolytic activity in amphibian tissues: a tissue culture assay publication-title: Pnas doi: 10.1073/pnas.48.6.1014 – volume: 31 start-page: 379 year: 2016 ident: B174 article-title: Extracellular vesicle-mediated modulation of angiogenesis publication-title: Histol Histopathol doi: 10.14670/HH-11-708 – volume: 56 start-page: 1679 year: 2008 ident: B139 article-title: Matrix metalloproteinase-9 interplays with the IGFBP2-IGFII complex to promote cell growth and motility in astrocytomas publication-title: Glia doi: 10.1002/glia.20719 – volume: 118 start-page: 851 year: 2017 ident: B99 article-title: PlGF knockdown decreases tumorigenicity and stemness properties of spheroid body cells derived from gastric cancer cells publication-title: J Cell Biochem doi: 10.1002/jcb.25762 – volume: 6 start-page: 396 year: 2014 ident: B120 article-title: Matrix metalloproteinases: the gene expression signatures of head and neck cancer progression publication-title: Cancers doi: 10.3390/cancers6010396 – volume: 18 start-page: 884 year: 2010 ident: B51 article-title: Tumors as organs: complex tissues that interface with the entire organism publication-title: Dev Cell doi: 10.1016/j.devcel.2010.05.012 – volume: 23 start-page: 4523 year: 2019 ident: B70 article-title: Increased Six1 expression in macrophages promotes hepatocellular carcinoma growth and invasion by regulating MMP-9 publication-title: J Cell Mol Med doi: 10.1111/jcmm.14342 – volume: 7 start-page: 89 year: 2018 ident: B1 article-title: New insights into the occurrence of matrix metalloproteases−2 and−9 in a Cohort of Breast Cancer Patients and Proteomic Correlations publication-title: Cells doi: 10.3390/cells7080089 – volume: 291 start-page: 27265 year: 2016 ident: B43 article-title: Differential receptor binding and regulatory mechanisms for the lymphangiogenic growth factors vascular endothelial growth factor (VEGF)-C and -D publication-title: J Biol Chem doi: 10.1074/jbc.M116.736801 – volume: 6 start-page: 7 year: 2017 ident: B190 article-title: Stromal modulators of TGF-β in cancer publication-title: J Clin Med doi: 10.3390/jcm6010007 – volume: 112 start-page: E2487 year: 2015 ident: B88 article-title: IL-33 activates tumor stroma to promote intestinal polyposis publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.1422445112 – volume: 19 start-page: 3 year: 2018 ident: B188 article-title: Distribution of M1 and M2 macrophages in tumor islets and stroma in relation to prognosis of non-small cell lung cancer publication-title: BMC Immunol doi: 10.1186/s12865-018-0241-4 – volume: 7 start-page: 5118 year: 2018 ident: B104 article-title: TGF-β-mediated exosomal lnc-MMP2-2 regulates migration and invasion of lung cancer cells to the vasculature by promoting MMP2 expression publication-title: Cancer Med doi: 10.1002/cam4.1758 – volume: 15 start-page: 221 year: 1997 ident: B36 article-title: Angiogenesis publication-title: Semin Reprod Med doi: 10.1055/s-2008-1068751 – volume: 214 start-page: 938 year: 2017 ident: B187 article-title: Cancer-promoting mechanisms of tumor-associated neutrophils publication-title: Am J Surg doi: 10.1016/j.amjsurg.2017.08.003 – volume: 102 start-page: 530 year: 2010 ident: B129 article-title: The role of MMP-9 in the anti-angiogenic effect of secreted protein acidic and rich in cysteine publication-title: Br J Cancer doi: 10.1038/sj.bjc.6605538 – volume: 287 start-page: 38716 year: 2012 ident: B137 article-title: Matrix Metalloproteinase-13 (MMP-13) directly and indirectly promotes tumor angiogenesis publication-title: J Biol Chem doi: 10.1074/jbc.M112.373159 – volume: 110 start-page: 441 year: 2014 ident: B101 article-title: Tumour-site-dependent expression profile of angiogenic factors in tumour-associated stroma of primary colorectal cancer and metastases publication-title: Br J Cancer doi: 10.1038/bjc.2013.745 – volume: 5 start-page: 76 year: 2018 ident: B52 article-title: Integrin-mediated delivery of drugs and nucleic acids for anti-angiogenic cancer therapy: current landscape and remaining challenges publication-title: Bioengineering doi: 10.3390/bioengineering5040076 – volume: 8 start-page: 205 year: 2017 ident: B59 article-title: IL-1β, IL-8, and matrix metalloproteinases-1,−2, and−10 are enriched upon monocyte-breast cancer cell cocultivation in a matrigel-based three-dimensional system publication-title: Front Immunol doi: 10.3389/fimmu.2017.00205 – volume: 110 start-page: e92 year: 2012 ident: B193 article-title: MMP-2 Regulates Erk1/2 phosphorylation and aortic dilatation in marfan syndrome publication-title: Circ Res doi: 10.1161/CIRCRESAHA.112.268268 |
| SSID | ssj0000650103 |
| Score | 2.6739776 |
| SecondaryResourceType | review_article |
| Snippet | During angiogenesis, new vessels emerge from existing endothelial lined vessels to promote the degradation of the vascular basement membrane and remodel the... |
| SourceID | doaj pubmedcentral proquest pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 1370 |
| SubjectTerms | angiogenesis and cancer immune system metalloproteinases MMP MT-MMP Oncology |
| Title | Role of Matrix Metalloproteinases in Angiogenesis and Cancer |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/31921634 https://www.proquest.com/docview/2336247141 https://pubmed.ncbi.nlm.nih.gov/PMC6915110 https://doaj.org/article/af6f90a4499b46a9bc6286338cefdcb4 |
| Volume | 9 |
| WOSCitedRecordID | wos000504208200001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: DOA dateStart: 20110101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2234-943X dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000650103 issn: 2234-943X databaseCode: M~E dateStart: 20110101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEB7aUEovpe9uH0GFHnpxYutlC3pJQ0IvG0ppYW9ClqXUEOSwuyk95bdnRnaW3dLSS33wwZbw8I2t-QaNvwF4H72vte5MESvjCqlMKDBXCVQ07pysuI-Vy80m6rOzZrEwX7ZafVFN2CgPPAJ36KKOpnQSmXkrtTOtp58pMbHyIXa-zUqgyHq2kqlxDVbUwGDU8sHB5jAOiRQLK3NAInvlThjKav1_opi_V0puhZ7TR_Bw4ozsaLT1MdwJ6Qncn0-74k_h49fhIrAhsjnp7f9i87Cm7fQswdAnDFMr1id2lM774ZyWtn7FXOrYMTl8-Qy-n558O_5cTF0RCq-4WhcRCQeyFOECNyo0jW47IXUU3FeSex6cjKpzSPtq1ZaqDHiQRrt0TmlZeSGew14aUngJTBoM-KZDZDnSJuHbrsHc2nDfNF7VXM7g4BYk6yfJcOpccWExdSBULaFqCVWbUZ3Bh82Ey1Et4-9DPxHqm2Ekc50voPPt5Hz7L-fP4N2tzyx-FrTX4VIYrlaWC4zMGHhlNYMXow83jxKkAacFzq53vLtjy-6d1P_I0tvaIEOqylf_w_jX8IDgyLUx-g3srZdX4S3c8z_X_Wq5D3frRbOf32o8z69PbgCjzv0i |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+Matrix+Metalloproteinases+in+Angiogenesis+and+Cancer&rft.jtitle=Frontiers+in+oncology&rft.au=Saray+Quintero-Fabi%C3%A1n&rft.au=Rodrigo+Arreola&rft.au=Enrique+Becerril-Villanueva&rft.au=Julio+C%C3%A9sar+Torres-Romero&rft.date=2019-12-06&rft.pub=Frontiers+Media+S.A&rft.eissn=2234-943X&rft.volume=9&rft_id=info:doi/10.3389%2Ffonc.2019.01370&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_af6f90a4499b46a9bc6286338cefdcb4 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2234-943X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2234-943X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2234-943X&client=summon |